Direct-to-consumer genetic testing: Helpful, harmful, or pure entertainment?

Community Oncology

Volumn 8, Issue 6, 2011, Pages 263-268

  Pirzadeh Miller, Sara ^a   Bellcross, Cecelia ^b   Robinson, Linda ^c   Matloff, Ellen T ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; AWARENESS; BRCA GENE; BRCA2 GENE; CONSUMER HEALTH INFORMATION; DIAGNOSTIC ACCURACY; FAMILY HISTORY; GENE; GENE MUTATION; GENE TECHNOLOGY; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HUMAN; ONCOGENE; PREDICTIVE VALUE; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; VIGNETTE;

EID: 80052664948     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(12)70021-9     Document Type: Review

References (33)

1. Myers MF, Chang M-H, Jorgensen C, et al. Genetic testing for susceptibility to breast and ovarian cancer: evaluating the impact of a direct-to-consumer marketing campaign on physicians' knowledge and practices. Genet Med 2006;8:361-370.
2. Janssens CJW, Gwinn M, Bradley LA, et al. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalized health interven-tions. Am J Hum Genet 2008;82:593-599.
3. Magnus D, Cho M, Cook-Deegan B. Direct-to-consumer genetic tests: beyond medical regulation? Genome Med 2009;1:17.
4. Eng C, Sharp R. Bioethical and clinical dilemmas of direct-to-consumer personal ge-nomic testing: the problem of misattributed equivalence. Sci Transl Med 2010;2(17):17cm5.
5. Khoury MJ, McBride CM, Schully SD, et al. Centers for Disease Control and Prevention. The scientific foundation for personal ge-nomics: recommendations from a National In-stitutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med 2009;11:559-567.
6. Wacholder S, Haretge P, Prentice R. Performance of common genetic variants in breast cancer risk models. N Engl J Med 2010;363:986-993.
7. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007;25:1329-1333.
8. Mealiffe M, Stokowski R, Thees B, Pren-tice R, Pettinger M, Hinds D. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst 2010;102:1618-1627.
9. Decode Genetics Web site. http://www.decode.com. Accessed March 13, 2011.
10. 23andME Web site. http://www.23andMe.com. Accessed March 13, 2011.
11. Navigenics Web site. http://www.navi-genics.com. Accessed March 13, 2011.
12. Proactive Genomics Web site. http://www.proactivegenomics.com. Accessed March 13, 2011.
13. Ng PC, Murray SS, Levy S, Venter JC. An agenda for personalized medicine. Nature 2009;461:724-726.
14. GAO report: Direct-to-consumer ge-netic tests: misleading test results are further complicated by deceptive marketing and other questionable practices. GAO-10-847T July 22, 2010. http://www.gao.gov/products/GAO-10-847T. Accessed March 13, 2011.
15. Udesky L. The ethics of direct-to-consumer genetic testing. Lancet 2010;376:1377-1378.
16. Berndt S, Platz E, Fallin M. Mismatch repair polymorphism and the risk of colorectal cancer. Int J Cancer 2007;120:1548-1554.
17. da Silva TD, Felipe AV, de Lima JM, Oshima CT, Forones NM. N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer. World J Gastroenterol 2011;17:760-765.
18. Hogarth S, Javitt G, Melzer D. The cur- rent landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues. Annu Rev Genomics Hum Genet 2008;9:161-182.
19. Gray S, Olopade OI. Direct-to-consumer marketing of genetics tests for cancer: buyer beware. J Clin Oncol 2003;21:3191-3193.
20. Gollust SE, Chandros Hull S, Wil- fond BS. Limitations of direct-to-consumer advertising for clinical genetic testing. JAMA 2002;288:1762-1767.
21. Wolfberg AJ. Genes on the Web: direct-to-consumer marketing of genetic testing. N Engl J Med 2006;355:543-545.
22. European Society of Human Genetics. Statement of the ESHG on direct-to-consum- er genetic testing for health-related purposes. Eur J Hum Genet 2010;18:1271-1273.
23. Williams-Jones B. "Be ready against cancer, now": direct-to-consumer advertising for genetic testing. New Genet Soc 2006;25:89-107.
24. Kolar K, Liu T, St Pierre J, Khoury MJ. Heath care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests. Genet Med 2009;11:595.
25. McGuire AL, Diaz C, Wang T, et al. Social networkers' attitudes toward direct-to- consumer personal genome testing. Am J Bio- ethics 2009;9:3-10.
26. McGuire AL, Burke W. An unwelcome side effect of direct-to consumer personal genome testing: raiding the medical commons. JAMA 2008;300:2669-2671.
27. Caufield T, Ries NM, Ray PN, Shu-man C, Wilson B. Direct-to-consumer genetic testing: good, bad or benign? Clin Genetic 2010;77:101-105.
28. Mykitiuk R. Caveat emptor: direct-to-consumer supply and advertising of genetic testing. Clin Invest Med 2004;27:23-32.
29. American College of Medical Genetics (ACMG) statement on direct-to-consum- er genetic testing: April 7, 2008. http://www.acmg.net/AM/Template.cfm?Section=Policy_Statements&Template=/CM/ContentDisplay.cfm&ContentID=2975, Accessed March 13, 2011.
30. Hudson K, Javitt G, Burke W. ASHG statement on direct-to-consumer genetic testing in the United States. Obstet Gynecol 2007;110:1392-1395.
31. NSGC statement on direct to consumer genetic testing. Adopted 2007. http://www.nsgc.org/Media/PositionStatements/tab-id/330/Default.aspx#DTC. Accessed March 13, 2011.
32. AMA Press Release, February 23, 2011. AMA to FDA: genetic testing should be con- ducted by qualified health professionals. http://www.ama-assn.org/ama/pub/news/news/ge-netic-testing-qualified-professionals.page. Ac- cessed March 8, 2011.
33. Annes JP, Giovanni MA, Murray MF. Risk of presymptomatic direct-to-consumer genetic testing. N Engl J Med 2010;363:1100-1101.